Strategies for Assessing and Addressing Confounding
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
What is an Experiment?
Desensitization and Tachyphylaxis
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 3, 2026

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Brooke E Nichols1, Charles A B Boucher2, David A M van de Vijver2
1Center for Global Health and Development, Boston University, Boston, MA, 02118, USA; Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
No abstract available in PubMed .
09:09Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
Published on: August 17, 2022
13:20Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance
Published on: December 5, 2025